Clinical Trials Logo

Dysphagia clinical trials

View clinical trials related to Dysphagia.

Filter by:

NCT ID: NCT02960737 Recruiting - Stroke Clinical Trials

Dysphagia Evaluation After Stroke- Effect Oral Neuromuscular Training on Swallowing Dysfunction

DESIRE
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of a specific rehabilitation program with an oral device used in stroke patients with persistent oral-and pharyngeal dysphagia.

NCT ID: NCT02927691 Completed - Parkinson's Disease Clinical Trials

Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial

Start date: September 2016
Phase: Phase 2
Study type: Interventional

Currently, there are no efficacious behavioral treatment approaches to address uncompensated aspiration, or aspiration without appropriate cough response, in Parkinson's disease (PD). This is of particular public health concern given that aspiration pneumonia is the leading cause of death in persons with PD. The overarching aim of the proposed study is to determine the efficacy of two distinct intensive rehabilitation paradigms, expiratory muscle strength training (EMST) and sensorimotor treatment for airway protection (smTAP), on airway protective clinical outcomes in persons with PD and dysphagia. The investigators anticipate the results will lead to reductions in the risks associated with airway protective deficits.

NCT ID: NCT02926014 Completed - Dysphagia Clinical Trials

Lingual Tonsil Hypertrophy Grading and Its Relation to Sociodemographic Factors and Clinical Symptoms

Start date: October 2014
Phase: N/A
Study type: Interventional

The aim of this research was to evaluate the lingual tonsil hypertrophy (LTH) grading of patients with dysphagia using videolaryngoscopy and determine the relation of LTH grades to sociodemographic factors and clinical symptoms.

NCT ID: NCT02874352 Not yet recruiting - Dysphagia Clinical Trials

Incidence of Dysphagia in Intensive Care Patients With Tracheostomy

Start date: October 2016
Phase: N/A
Study type: Interventional

This study will inform the feasibility of the High Resolution Impedance Manometry (HRIM) system combined with Automated Impedance Manometry (AIM) analysis as a screening tool for dysphagia and aspiration for the intensive care population with tracheostomy. This pilot study aims to determine the incidence of dysphagia and aspiration risk in intensive care patients with tracheostomy and the investigators hypothesise that the incidence of dysphagia in intensive care patients with tracheostomy will be higher than in an age matched population.

NCT ID: NCT02845362 Completed - Dysphagia Clinical Trials

Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases

Start date: August 2016
Phase: N/A
Study type: Interventional

Measurements of dysphagia severity are important when making management decisions and in the objective evaluation of swallowing impairments. The Sydney Swallow Questionnaire (SSQ) is a validated self-report inventory using a visual analogue scale. This questionnaire permits a quantitative, sensitive, specific, repeatable and easily responsive evaluation of dysphagia in different pathology. Opposed to largely used videofluoroscopy swallowing study and endoscopy examinations, the SSQ is noninvasive, less expensive, avoids radiation exposure and enables a readily available assessment. Validated French version is not yet available. In the first phase of the study the investigators will validated this translation in dysphagic patients and control. Secondly, the investigators will validate the SSQ in Neuromuscular patients.

NCT ID: NCT02838771 Completed - Dysphagia Clinical Trials

Validation and Clinical Application of Dysphagia Screening Questionnaire

Start date: March 2011
Phase: N/A
Study type: Interventional

The aim of this research was to develop a dysphagia screening measure and evaluate the prevalence of dysphagia and its clinical manifestation in different in age population groups.

NCT ID: NCT02825927 Completed - Quality of Life Clinical Trials

Swallowing Function, Oral Health, and Food Intake in Old Age

SOFIA
Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a specific rehabilitation program with oral screen used in an elderly population with dysphagia can improve elderly's swallowing capacity.

NCT ID: NCT02822456 Recruiting - Dysphagia Clinical Trials

Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing

Start date: December 2015
Phase: N/A
Study type: Interventional

The aim of this study is to test the clinical effectiveness of IOE tube using individually customized 3-dimentional printed guiding tube as an alternative to Levin tube feeding when unconscious patients have no choice but tube feeding.

NCT ID: NCT02822391 Completed - Stroke Clinical Trials

Oral Tactile Sensitivity in Stroke Patients

Start date: February 2012
Phase: N/A
Study type: Observational

Orofacial impairment following stroke frequently involves a reduced chewing performance and dysphagia. This study investigated the sensitivity of oral tissues following stroke and its potential impact on chewing efficiency. The following two Null-hypotheses (H0) were tested: i. Post-stroke patients do not show a reduced intra-oral sensitivity compared to a healthy controls. ii. Intra-oral sensitivity is not correlated to chewing efficiency.

NCT ID: NCT02724761 Not yet recruiting - Postoperative Pain Clinical Trials

Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion

Start date: September 2016
Phase: N/A
Study type: Interventional

Our double-blinded, randomized control trial will assess the effect of nebulized racemic epinephrine inpatients undergoing anterior cervical discectomy and fusion (ACDF) procedures. The investigators have had success in managing post-operative dysphagia in patients undergoing ACDF with the administration of this drug. Half of the participants will review nebulized epinephrine. The other half will receive placebo.